Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ImageneBio, Inc. Director's Dealing 2024

Mar 5, 2024

34275_dirs_2024-03-05_97ad8bf0-39ac-483e-85e6-3ab6d5bad832.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Ikena Oncology, Inc. (IKNA)
CIK: 0001835579
Period of Report: 2024-02-29

Reporting Person: Germa Caroline (N/A)

More from ImageneBio, Inc.

Regulatory Filings 2026
May 7
Annual Report 2026
Apr 30
Regulatory Filings 2026
Apr 13
Regulatory Filings 2026
Apr 13
Director's Dealing 2026
Mar 18
Regulatory Filings 2026
Mar 17
Regulatory Filings 2026
Feb 17
Regulatory Filings 2026
Feb 17
Major Shareholding Notification 2026
Feb 13
Major Shareholding Notification 2026
Feb 12
View all filings →